MedPath

BAYER HEALTHCARE PHARMACEUTICALS INC.

BAYER HEALTHCARE PHARMACEUTICALS INC. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:5
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

32

FDA:30
NMPA:2

Drug Approvals

Copanlisib Hydrochloride for Injection

Product Name
奥罗巴
Approval Number
国药准字HJ20230056
Approval Date
May 19, 2023
NMPA

Darolutamide Tablets

Product Name
诺倍戈
Approval Number
国药准字HJ20210010
Approval Date
Mar 15, 2023
NMPA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)
No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath